Alopecia, Androgenetic
19
1
3
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
10.5%
2 terminated out of 19 trials
83.3%
-3.2% vs benchmark
26%
5 trials in Phase 3/4
60%
6 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (19)
Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia
A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.
Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia
Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions
A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)
Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvement of Androgenetic Alopecia
A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia
STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia
Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia
Role of Vitamin D in Androgenetic Alopecia
Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL)
A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia